DRUG
Misoprostol
25 mcg vaginally every 6 hours
Status
Recruiting
Phase
Phase 3
Enrollment
281
Locations
2
Results
Not posted
Publications
0
Study summary
What the protocol is testing.
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
Full detailed description
This randomized controlled trial will include patients with a BMI greater than 30 at the time of admission for their induction of labor. Patients will be randomized to either misoprostol or Pitocin to begin induction of labor, alongside the standard foley catheter, and the primary outcome of interest will be length of time from start of induction until delivery.
Interventions
Treatment arms and agents.
DRUG
Pitocin
3-6 mL intravenously every hour
Timeline
From registration to results.
First posted
Feb 14, 2024
Study start
Jul 2, 2024
Primary completion
Aug 2026
Study completion
Aug 2026
Results posted
Not reported
Registry updated
Jul 24, 2026
Outcomes
What the study measures.
Primary outcomes
Time from induction to delivery
Time frame · start of induction until delivery
Simple measure calculating time from start of induction until delivery of neonate.
Secondary outcomes
Delivery outcome
Time frame · at delivery
Simple determination whether patient had a vaginal delivery or delivered by cesarean section.
Eligibility
Who can take part.
- Minimum age
- 18 Years
- Maximum age
- Not reported
- Sex
- FEMALE
- Healthy volunteers
- No
Inclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI \> = 30 Exclusion Criteria: \- Pregnant patient presenting to labor \& delivery for induction of labor with BMI \< 30
Study locations
2 registered sites.
United States. Showing up to 24 locations stored in the fast local snapshot.
Mount Sinai Hospital
New York, New York, United States
Bronx Care Health System
The Bronx, New York, United States
Publications
Results and literature.
No PMID-linked publications were present in this registry snapshot.
Related trials
More studies on Oxytocin.
NCT IDStudyPhase / statusEnrollmentUpdated
Efficacy of Intravenous Oxytocin to Speed Recovery After THA
Wake Forest University Health Sciences · Total Hip Arthroplasty
Phase 2
Enrolling by invitation
80
2026-07
Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery
Yale University · Pain · Pituitary Surgery
Phase 2
Not yet recruiting
75
2026-07
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
Medical University of South Carolina · PTSD · Alcohol Use Disorder
Phase 2
Completed
175
2026-07
Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening
University Hospital, Tours · Cervical Ripening · Unfavorable Cervix
Phase 3
Recruiting
1,494
2026-07
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Elizabeth Austen Lawson · Vasopressin Deficiency
Phase 1
Recruiting
40
2026-07
Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease
Massachusetts General Hospital · Arginine Vasopressin Deficiency · Oxytocin Deficiency
Early Phase 1
Recruiting
20
2026-07
Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction
Aalto University · Induction of Birth · Cervical Ripening
Not applicable
Recruiting
40
2026-07
Ripening Approaches for Prompt Induction and Delivery - Sequential Versus Concurrent Dilapan-S and Misoprostol to Achieve Vaginal Delivery (RAPID-DS)
Ochsner Health System · Nulliparous Women Who Scheduled for Labor Induction · Pregnancy
Not applicable
Not yet recruiting
260
2026-07
Related PeptideStat pages
Put the record in context.
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.